发明名称 Oxygen enhancing membrane systems for implantable devices
摘要 The present invention relates generally to systems and methods for increasing oxygen availability to implantable devices. The preferred embodiments provide a membrane system configured to provide protection of the device from the biological environment and/or a catalyst for enabling an enzymatic reaction, wherein the membrane system includes a polymer formed from a high oxygen soluble material. The high oxygen soluble polymer material is disposed adjacent to an oxygen-utilizing source on the implantable device so as to dynamically retain high oxygen availability to the oxygen-utilizing source during oxygen deficits. Membrane systems of the preferred embodiments are useful for implantable devices with oxygen-utilizing sources and/or that function in low oxygen environments, such as enzyme-based electrochemical sensors and cell transplantation devices.
申请公布号 US8909314(B2) 申请公布日期 2014.12.09
申请号 US201113187277 申请日期 2011.07.20
申请人 DexCom, Inc. 发明人 Petisce James R.;Tapsak Mark A.;Simpson Peter C.;Carr-Brendel Victoria E.;Brauker James H.
分类号 A61B5/145;A61B5/1468;A61B5/1473;A61B5/1486 主分类号 A61B5/145
代理机构 Knobbe, Martens, Olson & Bear, LLP. 代理人 Knobbe, Martens, Olson & Bear, LLP.
主权项 1. An implantable device for continuous in vivo measurement of an analyte concentration in a host, the implantable device comprising: a sensor configured to operatively connect with electronic circuitry, wherein the sensor is configured to generate a signal indicative of a concentration of an analyte in a host; and a membrane located over the sensor, wherein the membrane has a thickness of from about 3 microns to about 100 microns, wherein the membrane has an oxygen permeability of from about 3 Barrers to about 1000 Barrers, and wherein the membrane has an oxygen solubility that is at least about three times greater than an oxygen solubility of water.
地址 San Diego CA US